`
`Curriculum Vitae
`Peter Draper
`
`
`
`Peter Draper M.Sc., C. Chem., MRIC
`
`Vice President Product Innovation (R&D)
`
`Catalent Pharma Solutions
`
`2125 Ambassador Drive
`
`Windsor, Ontario
`
`Canada N9C 3R5
`
`Professional Summary
`
`Senior Pharmaceutical Scientist/Manager with experience in the design, development and
`
`manufacture of Pharmaceutical dosage forms, particularly soft gel capsules.
`
`Education
`
`• 1972 – Honors Graduate of the Royal Society of Chemistry (UK)
`• 1974 - Master’s Degree in Pharmaceutical Sciences Glasgow School of Pharmacy (UK)
`• Member of the Royal Society of Chemistry (Retired)
`• Chartered Chemist of the Royal Society of Chemistry (Retired)
`
`Professional Employment
`
`Reckitt and Colman UK (Reckitt Benckiser)
`
`At the time of employment, Reckitt and Colman Pharmaceutical Company was engaged in the
`
`research, development and manufacture of new pharmaceutical active ingredients and
`
`pharmaceutical products based on drug delivery technologies.
`
`A successful career was progressed in a number of positions, providing in-depth experience of
`
`pharmaceutical dosage form design and development and the associated regulatory processes.
`
`• Undergraduate Laboratory Technician - 1964 to 1972
`
`Laboratory assistant supporting the analyses of pharmaceutical materials and finished products
`
`• Analytical Chemist 1974 to1988
`
`Development of analytical methods associated with the development and stability evaluation of
`
`pharmaceutical active ingredients and a wide range of pharmaceutical dosage forms and
`
`associated primary packaging.
`
`Management of the Analytical functions associated with the development of new
`
`Pharmaceutical Products.
`
`
`
`
`
`Peter Draper
`
`December 12, 2017
`
`Page 1 of 1
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1002, Pg. 1 of 3
`
`

`

`Curriculum Vitae
`Peter Draper
`
`• Technical Development Manager 1988 to 1990
`
`Evaluation of new products from within the company and external suppliers, and
`
`coordination of product developments between the Technical and the Market
`
`Development functions
`
`
`
`
`
`RP Scherer North America -1991 to 2005
`
` Technical Director RP Scherer (UK) then transferred to RP Scherer North America. Responsible for
`
`coordination of the development of new Soft Gel capsules and management of a number of major
`
`projects associated with the development and manufacture of soft gel capsule dosage forms and
`
`associated processes.
`
`Gained an in-depth experience of soft gel capsule dosage form design, development and
`
`manufacture, particularly complex formulations for the optimum delivery of active pharmaceutical
`
`ingredients.
`
`Provided relevant technical support to the Sales and Marketing functions in Client meetings and
`
`presentations.
`
`Major projects included:
`
`• Establishment and management of a specialist suite for the development and
`
`manufacture of soft gel capsules containing cytotoxic active ingredients.
`
`• Closed vessel processing of capsule fill materials.
`
`• Project leader for the identification and development of soft gel capsules based on
`
`non-gelatin hydrocolloids.
`
`
`
`Gel-Cell Capsules 2005 to 2006
`
`• General Manager of the Gel-Cell Company concerned with the development and contract
`
`manufacture of consumer pharmaceutical and nutritional Soft Gel products In Canada
`
`
`
`Accucaps Industries Limited
`
`• Senior Director of Development -2006 to 2009 - Established and developed the
`
`technical/scientific team and associated project management processes for the design and
`
`development of soft gel capsules for clients. .
`
`• Vice President of Product Development 2010 to 2015 - Member of the Accucaps Industries
`
`Executive responsible for product development and technical support of Sales and Marketing.
`
`Peter Draper
`
`December 12, 2017
`
`Page 2 of 2
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1002, Pg. 2 of 3
`
`

`

`Curriculum Vitae
`Peter Draper
`
`Initiated and progressed the Accucaps portfolio of new soft gel capsule technologies and
`
`associated products
`
`• Vice President of New Technologies and IP 2015 to 2017 – Evaluation of new soft gel related
`
`technologies and dosage form designs and progression of a portfolio of patent applications
`
`
`
`
`
`Catalent Pharma Solutions
`
`• Vice President Product Innovation (R&D) 2017 – Technical support as necessary for the
`
`progression of a portfolio of patent applications initiated by Accucaps Industries Ltd., and
`
`Member of the Catalent Intellectual Property Review Board concerned with soft gel capsules.
`
`Peter Draper
`
`December 12, 2017
`
`Page 3 of 3
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1002, Pg. 3 of 3
`
`